Commentary on Moodley S et al. “Shouldn’t Propranolol be Used to Treat All Hemangiomas?” and Dr. Blei’s Invited Commentary

Julia P. Neckman1, Roy G. Geronemus1
1Laser and Skin Surgery Center of New York, New York, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Moodley ST, Hudson DA, Adams S, Adams KG (2015) Shouldn’t propranolol be used to treat all haemangiomas? Aesthet Plast Surg 39:963–967

Blei F (2015) Commentary on Moodley S et al. “Shouldn’t Propranolol be Used to Treat All Hemangiomas?”. Aesthetic Plast Surg. doi: 10.1007/s00266-015-0515-7

Dasgupta R, Fishman SJ (2014) ISSVA classification. Semin Pediatr Surg 23:158–161. doi: 10.1053/j.sempedsurg.2014.06.016

Rizzo C, Brightman L, Chapas AM et al (2009) Outcomes of childhood hemangiomas treated with the pulsed-dye laser with dynamic cooling: a retrospective chart analysis. Dermatol Surg 35:1947–1954

Leonardi-Bee J, Batta K, O’Brien C, Bath-Hextall FJ (2011) Interventions for infantile haemangiomas (strawberry birthmarks) of the skin. Cochrane Database System Rev 5:Cd006545. doi: 10.1002/14651858.CD006545.pub2

Hunzeker CM, Geronemus RG (2010) Treatment of superficial infantile hemangiomas of the eyelid using the 595-nm pulsed dye laser. Dermatol Surg 36:590–597

Reddy KK, Blei F, Brauer JA et al (2013) Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser. Dermatol Surg 39:923–933